Trends and Finance

Vertex to pay $25M upfront to scale cell manufacturing technology

By LabPulse.com staff writers

As part of the deal, Vertex was also willing to pay up to $215 million in milestones achieved in connection with the development of a scaled-up process for fully differentiated islet cells.

April 25, 2024

Labcorp buys Invitae portfolio for $239M

By LabPulse.com staff writers

Labcorp was the winning bidder in the court-supervised auction of Invitae's assets, obtaining substantially all of the San Francisco-based company's business for $239 million in cash consideration with other noncash consideration.

April 26, 2024

Bristol Myers Squibb to reduce workforce in restructuring plan

By LabPulse.com staff writers

As part of a restructuring plan intended to cut $1.5 billion in costs, Bristol Myers Squibb plans to cut about 6% of its workforce, according to the firm.

April 25, 2024

U.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuit

By LabPulse.com staff writers

The Patents Court of the High Court of England and Wales has ruled that two patents owned by Bio-Techne are invalid, rejecting a patent infringement lawsuit filed by Bio-Techne/ACD in the U.K. against Molecular Instruments.

April 24, 2024

Bio-Techne files EU patent infringement suit against Molecular Instruments

By LabPulse.com staff writers

Life sciences company Bio-Techne has filed a lawsuit against Molecular Instruments in the pan-European Unified Patent Court, alleging patent infringement of its RNAscope in situ hybridization technology.

April 23, 2024

Bruker to acquire NanoString for $392.6M

By LabPulse.com staff writers

NanoString has reached an agreement with Bruker in which Bruker will purchase substantially all of NanoString's assets for approximately $392.6 million in cash, as well as assume certain NanoString liabilities.

April 18, 2024

DermTech receives delisting warning from Nasdaq

By LabPulse.com staff writers

Melanoma diagnostics company DermTech announced that it has received a delisting warning from Nasdaq.

April 17, 2024

Nightingale Health to open U.S. lab, collaborate with Englander Institute at Weill Cornell

By LabPulse.com staff writers

Preventive healthcare company Nightingale Health will open a laboratory in the U.S. In addition, the Englander Institute for Precision Medicine at Weill Cornell Medicine has signed on as its first customer.

April 17, 2024

Co-Diagnostics opens manufacturing facility in Utah

By LabPulse.com staff writers

Molecular diagnostics firm Co-Diagnostics has opened a new manufacturing facility in South Salt Lake, UT, holding a ribbon-cutting event to inaugurate the facility on April 11.

April 16, 2024

OraSure discloses cybersecurity breach

By LabPulse.com staff writers

OraSure Technology disclosed a cybersecurity incident involving data theft that occurred in late March.

April 15, 2024

Seaport Therapeutics launches with $100M financing round

By LabPulse.com staff writers

Clinical-stage biopharmaceutical company Seaport Therapeutics launched with the announcement of the closing of a $100 million oversubscribed series A financing round.

April 9, 2024

Johnson & Johnson to acquire Shockwave Medical

By LabPulse.com staff writers

Johnson & Johnson will acquire Shockwave Medical, expanding Johnson & Johnson MedTech's position in the growing medtech market for cardiovascular intervention.

April 8, 2024

Page 1 of 133

Next Page